(Q48260298)

10 February 2018

title

Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan). (English)

1 reference

10 February 2018

author name string

M Sakurai

1

1 reference

10 February 2018

T Shinkai

2

1 reference

10 February 2018

K Eguchi

3

1 reference

10 February 2018

Y Sasaki

4

1 reference

10 February 2018

T Tamura

5

1 reference

10 February 2018

K Miura

6

1 reference

10 February 2018

Y Fujiwara

7

1 reference

10 February 2018

A Otsu

8

1 reference

10 February 2018

N Horiuchi

9

1 reference

10 February 2018

H Nakano

10

1 reference

10 February 2018

publication date

1 January 1987

1 reference

10 February 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

10 February 2018

volume

113

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

563-566

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00390866

exact match

0 references

cites work

Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)

1 reference

12 December 2020

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

1 reference

12 December 2020

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin

1 reference

12 December 2020

Illusion and reality: practical pitfalls in interpreting clinical trials

1 reference

12 December 2020

Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lung

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

12 December 2020

Prognostic factors for survival in patients with inoperable lung cancer.

1 reference

12 December 2020

Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer

1 reference

12 December 2020

Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.

1 reference

12 December 2020

Importance of prognostic factors in cancer clinical trials

1 reference

12 December 2020

Treatment of non-small-cell lung cancer

1 reference

12 December 2020

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens

1 reference

12 December 2020

Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00390866

1 reference

10 February 2018

1 reference

10 February 2018